Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by الشركة الأردنية لأنتاج الأدويةfiledCriticalالشركة الأردنية لأنتاج الأدوية
Priority to JO200613ApriorityCriticalpatent/JO2572B1/en
Application grantedgrantedCritical
Publication of JO2572B1publicationCriticalpatent/JO2572B1/en
The present invention relates to a controlled- release pharmaceutical composition comprising at least one active agent and an inactive matrix, said matrix comprising a mixture of hydrophilic polysaccharide polymers comprising xanthan gum and salts and derivatives thereof, and further comprising sodium alginate and salts and derivatives thereof, characterized in that the ratio of said active agent and said hydrophilic polysaccharide polymer mixture is in the range from about 1:1 to about 1:5 and to the preparation and use of said composition
Pharmaceutical composition containing a solid dispersion with a polymer matrix containing a uniform polydextrose phase and a uniform phase of a polymer different from polydextrose.